It was also observed that patients with EMAS linked to SLC6A1 gene variants achieved seizure remission after being treated with medications such as valproate, levetiracetam, or zonisamide, while some showed partial improvement when lamotrigine was combined with valproate. Here, SLC6A1 is linked to epilepsy with myoclonic atonic seizures.